Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17259 | 545 | 38.5 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2418 | 3679 | SPLUNC1//ENDOTOXIN REMOVAL//POLYMYXIN B IMMOBILIZED FIBER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN B EXPRESSION | Author keyword | 1 | 100% | 0% | 2 |
2 | ENDOTOXIN NEUTRALIZATION | Author keyword | 1 | 33% | 1% | 3 |
3 | MOL MECH INFECT | Address | 1 | 33% | 0% | 2 |
4 | ADRENALECTOMIZED RAT | Author keyword | 1 | 50% | 0% | 1 |
5 | ANTI INFLAMMATORY NUTRIENTS | Author keyword | 1 | 50% | 0% | 1 |
6 | APOLIPOPROTEIN COMPOSITION | Author keyword | 1 | 50% | 0% | 1 |
7 | APOLIPOPROTEIN I | Author keyword | 1 | 50% | 0% | 1 |
8 | CHOLESTEROL TRIGLYCERIDES | Author keyword | 1 | 50% | 0% | 1 |
9 | CNR IASI SHOCK | Address | 1 | 50% | 0% | 1 |
10 | COLESTIPOL FEEDING | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEPATIC LIPID SYNTHESIS | 13 | 71% | 2% | 10 |
2 | ENDOGENOUS LIPOPROTEINS | 4 | 75% | 1% | 3 |
3 | CHYLOMICRONS ALTER | 4 | 56% | 1% | 5 |
4 | NECROSIS FACTOR RELEASE | 3 | 39% | 1% | 7 |
5 | INJECTED LIPOPOLYSACCHARIDE | 3 | 57% | 1% | 4 |
6 | SALMONELLA TYPHIMURIUM LIPOPOLYSACCHARIDES | 3 | 31% | 2% | 9 |
7 | CYTOKINE TOLERANCE | 3 | 100% | 1% | 3 |
8 | DISPOSAL MECHANISMS | 3 | 60% | 1% | 3 |
9 | LOW LIPID CONCENTRATIONS | 2 | 67% | 0% | 2 |
10 | HEPATIC TRIGLYCERIDE PRODUCTION | 1 | 38% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host | 2004 | 512 | 346 | 33% |
Dyslipidemia and inflammation: an evotutionary conserved mechanism | 2005 | 127 | 195 | 35% |
Plasma lipoproteins are important components of the immune system | 2010 | 13 | 76 | 22% |
The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity | 2000 | 34 | 76 | 51% |
High-density lipoproteins in sepsis and septic shock: Metabolism, actions, and therapeutic applications | 2004 | 99 | 165 | 29% |
HYPOCHOLESTEROLEMIA IN CLINICALLY SERIOUS CONDITIONS - REVIEW | 2008 | 8 | 79 | 38% |
Saturated fat, carbohydrates and cardiovascular disease | 2011 | 18 | 53 | 15% |
The role of high density lipoprotein in sepsis | 2001 | 36 | 71 | 34% |
The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism | 2006 | 26 | 71 | 18% |
Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis | 2013 | 21 | 145 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL MECH INFECT | 1 | 33% | 0.4% | 2 |
2 | CNR IASI SHOCK | 1 | 50% | 0.2% | 1 |
3 | IASI PATHOPHYSIOL SHOCK | 1 | 50% | 0.2% | 1 |
4 | KRALOVSKE VINOHRADY HOSP | 1 | 50% | 0.2% | 1 |
5 | LUND HOSP | 1 | 50% | 0.2% | 1 |
6 | MRC INFLAMMAT MED | 1 | 50% | 0.2% | 1 |
7 | METAB SECT 111F | 0 | 11% | 0.7% | 4 |
8 | INTENS CARE CLIN TOXICOL | 0 | 14% | 0.6% | 3 |
9 | INFECT DIS UNIT PEDIAT | 0 | 33% | 0.2% | 1 |
10 | KLINIKUM KROELLWITZ | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000133991 | MD 2//CD14//LIPOPOLYSACCHARIDE BINDING PROTEIN |
2 | 0.0000121110 | GLUCOSE DYSHOMEOSTASIS//HYG CHEM 1//CANC AOBA KU |
3 | 0.0000101720 | ASSOC CARDIAC//ASSOC RIC CARDIOL//CLIN EXPT MED 2 |
4 | 0.0000097128 | ANTILIPID A//ELEBUTE SCORE//ANTIBIOTIC INDUCED ENDOTOXIN RELEASE |
5 | 0.0000084865 | METHYL PALMITATE//GOMPHRENOL//30 NORMEDICAGENIC ACID |
6 | 0.0000082895 | TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB |
7 | 0.0000080851 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
8 | 0.0000075416 | LIPID EMULSION//LIPID EMULSIONS//LONG CHAIN TRIGLYCERIDES |
9 | 0.0000062659 | JOINT EFFUSIONS//JUMPING HORSE//MED BLOOD TRANSFUS UNIT |
10 | 0.0000058416 | SERUM AMYLOID A//AMYLOID ENHANCING FACTOR//AA AMYLOID |